Fund manager, analysts make the case for this ‘loathed’ pharma stock
October 30, 2017 at 04:49 AM EDT
Irish pharmaceutical giant Shire has seen its shares slump this year, turning in one of the worst performances among United Kingdom-listed blue chips. The bear case may have some cracks in it, however.
